Research published online yesterday, Feb. 3, 2017
This study demonstrates that melittin inhibits the formation of osteoclast-like MNCs
(osteoclast is a type of bone cell that breaks down bone tissue)
Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages
This study demonstrates that melittin inhibits the formation of osteoclast-like MNCs
(osteoclast is a type of bone cell that breaks down bone tissue)
Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages